MedTrace Logo

Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease

NCT00305201 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2016-05-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether Chilean children with history of Kawasaki disease have endothelial dysfunction years after the acute phase of the disease, and if this condition can be modified by treatment with statins.

Conditions

  • Kawasaki Disease

Interventions

DRUG

pravastatin

Sponsors & Collaborators

Principal Investigators

  • Arturo Borzutzky, MD · Pontificia Universidad Catolica de Chile, School of Medicine, Department of Pediatrics

  • Miguel Gutierrez, MD · Pontificia Universidad Catolica de Chile, School of Medicine, Department of Rheumatology and Clinical Immunology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-05-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00305201 on ClinicalTrials.gov